Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Eli Lilly obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist competition, says GlobalData

Eli Lilly’s tirzepatide (Mounjaro) has recently been approved by the National Medical Products Administration (NMPA) for treating obesity. This approval, based on the positive results from the SURMOUNT-CN clinical trial, makes tirzepatide the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for obesity treatment in China, which is expected to […]
Read more

India VC funding sees 45.3% YoY jump in H1 2024 despite 2.1% drop in deal volume, reveals GlobalData

India’s venture capital (VC) landscape during the first half (H1) of 2024 highlights a strategic shift towards relatively larger investments, as reflected by the 45.3% increase in disclosed funding value year-on-year (YoY) despite a 2.1% drop in deal volume. This trend signifies investors’ growing confidence in high-potential startups, with significant deals like Zepto’s $665 million […]
Read more

UK startups secure $7.7 billion VC funding despite fewer deals during H1 2024, reveals GlobalData

The UK startups secured $7.7 billion in venture capital (VC) funding during the first half (H1) of 2024, demonstrating a 2.8% year-on-year (YoY) increase in total value despite a 17.8% drop in deal volume. This divergence highlights a trend of selective investment, with significant backing for high-potential ventures. The substantial deals and investor enthusiasm suggest […]
Read more

Sahm Rule sparks US recession debate among influencers on social media platform X, reveals GlobalData

Sahm Rule activation has driven recession discussions to the forefront of the social media platform “X” in early August. This economic indicator signals a potential recession when the three-month moving average of the national unemployment rate exceeds its 12-month low by over 0.5%. With rising unemployment, a tightening job market, and increasing national debt, the […]
Read more

Biotech IPO raising soars sixfold QoQ in Q1 2024 amid renewed investor optimism, reveals GlobalData

Biotech initial public offerings (IPOs) surged in the first quarter (Q1) of 2024, with eight completed IPOs raising $3.72 billion—six times the amount raised in Q4 2023 and marking the highest quarterly biotech IPO value in over a year on a quarter-on-quarter (QoQ) comparison. This increase followed a two-year decline, indicating pent-up demand. Going forward, […]
Read more

8×8 unveils AI upgrades to contact center platform but suffers feature rollout delays, says GlobalData

8×8 has introduced AI-enhanced features to its contact center platform that elevate the customer experience and raise customer satisfaction. However, the integrated cloud contact center and unified communications platform provider faces challenges with delayed feature rollouts, potentially impacting its market reputation and competitive edge, says GlobalData, a leading data and analytics company. Gregg Willsky, Principal […]
Read more

2024 US Open Golf sees major sponsorship and prize pool milestones despite viewership dip, reveals GlobalData

The 2024 US Open Golf Championship showcased significant sponsorship investments, with financial services giant American Express leading the pack at $10.75 million annually. Despite a slight dip in viewership from 2023, the event remained a major draw, offering a record $12.5 million prize pool. Long-term sponsor partnerships underscore the event’s enduring appeal and financial stability, […]
Read more

Japan card payments market to grow by 10.8% in 2024, forecasts GlobalData

The Japan card payments market is forecast to grow by 10.8% in 2024 to reach JPY121.4 trillion ($866.8 billion), supported by the growing consumer preference for non-cash payments, forecasts GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that card payment value in Japan registered a growth of 15.8% in 2022, driven […]
Read more

Dual-voltage charging stations key for global EV adoption, says GlobalData

The automotive industry is undergoing a significant digital transformation focused on improving vehicle performance, safety, and sustainability. The key innovations driving this change include advanced EV discharge prediction, sophisticated collision avoidance systems, and dual-voltage charging stations. Among these, dual-voltage charging stations are particularly crucial in boosting EV adoption by supporting multiple charging standards and enhancing […]
Read more

APAC automotive electrical braking systems market to expand at 2.3% CAGR over 2024-29, forecasts GlobalData

The automotive industry has evolved significantly, especially in braking systems, enhancing comfort, safety, and technological integration. In the Asia-Pacific region, the adoption of cutting-edge technologies, such as electric vehicles (EV), is forecast to drive the growth of electrical braking systems market at a compound annual growth rate (CAGR) of 2.3% during 2024-2029, according to GlobalData, […]
Read more

APAC steering systems market to decline at 0.3% CAGR during 2024-2029, forecasts GlobalData

The automotive industry’s shift towards stricter emission standards is accelerating the transition to electrification, significantly impacting the steering systems market in the Asia-Pacific (APAC) region. Against this backdrop, the APAC steering systems market is forecast to register a negative compound annual growth rate (CAGR) of 0.3% over 2024-29, according to GlobalData, a leading data and […]
Read more

Zydus and Roche legal battle highlights need for affordable breast cancer treatments in India, says GlobalData

Zydus Life Sciences is engaged in a legal battle with Roche over its biosimilar, Sigrima, which is based on Roche’s Perjeta (Pertuzumab), targeting the human epidermal growth factor receptor 2-positive (HER2+) breast cancer market in India. As cases of HER2+ breast cancer rise in the country, the conflict underscores the critical need for cost-effective biosimilars […]
Read more

Sionna and AbbVie deal can redefine cystic fibrosis therapeutics, says GlobalData

Sionna Therapeutics, a US-based clinical-stage life sciences company specializing in cystic fibrosis (CF), has secured exclusive global rights to develop and commercialize multiple advanced compounds through a license agreement with AbbVie. This strategic acquisition includes Phase 2 compounds ABBV-2222 and ABBV-3067, and Phase 1 compound ABBV-2851, bolstering Sionna’s pipeline and its position in the CF […]
Read more

Southwest Airlines new seating policy sparks influencer debate on efficiency and brand identity, reveals GlobalData

Southwest Airlines Co, which is known for unique open-seating arrangement since its inception, has recently introduced assigned seating and extra legroom options. This significant change has sparked diverse opinions among the influencers on social media platform “X”. The varied reactions highlight the broader debate within the travel community about how this shift impacts the airline’s […]
Read more

South Korea defense expenditure to reach $54.7 billion in 2029 amid tensions with North Korea, observes GlobalData

South Korea’s defense spending is set to grow from $45.2 billion in 2024 to $54.7 billion in 2029, primarily driven by the persistent threat posed by North Korea and to achieve the broader goal of strengthening the former’s overall security posture. This growth underscores South Korea’s determination to continue investing in the procurement of modern […]
Read more
1 … 52 53 54 55 56 … 206